GREB1 and colorectal carcinoma: BRAF-mutated dysregulation of the MAPK/ERK signaling pathway results in the increased proliferation rate of CRC cells, while high expression of GREB1 may predict poor prognosis for CRC patients, suggesting GREB1 as a possible target for therapy [74].